Leukemia
Conditions
Interventions
This is a single-blind randomized clinical study carried out in the adult oncohematology ward of the Hospital Estadual Mário Covas in Santo André, São Paulo. Adult patients hospitalized in the oncohem
E02.779
E02.190.525.186
E02.760.169.063.500.387.875
Sponsors
Centro Universitário Faculdade de Medicina do ABC
Centro Universitário Faculdade de Medicina do ABC
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients hospitalized with a diagnosis of malignant hematological disease; age equal to or greater than 18 years; receiving chemotherapy or not; only after signing the free and informed consent form
Exclusion criteria
Exclusion criteria: Neurodegenerative diseases; heart failure, central nervous system metastases; difficulty in communicating and understanding properly; patients who refuse to participate; presence of fever, emesis and diarrhea; platelet count equal to or below 10,000/L; hemoglobin equal to or below 7 g/dL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the time of hospital discharge, the gain in global muscle strength will be evaluated through the dynamometer, improvement of fatigue or reduction of it, through the scores of the multidimensional scale of fatigue, improvement of functional capacity and quality of life, through the scores of the European scale organization for research and treatment of Cancer core quality of life questionnaire. Data from the groups will be compared with the first assessment at the time of admission. Patients in the intervention group are expected to have better results in the variables described above when compared to patients in the control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| At the time of hospital discharge, the gain in global muscle strength will be evaluated through the dynamometer, improvement of fatigue or reduction of it, through the scores of the multidimensional scale of fatigue, improvement of functional capacity and quality of life, through the scores of the European scale organization for research and treatment of Cancer core quality of life questionnaire. The individual data of the participants will be evaluated, within their respective groups, both intervention and control, in order to verify if there was a worsening of the variables at the end of the hospitalization. | — |
Countries
Brazil
Contacts
Public ContactBruna de Souza
Centro Universitário Faculdade de Medicina do ABC
Outcome results
None listed